EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Efficacy and Safety of Exosomes from Whartons Jelly-Derived Mesenchymal Stem Cells in Patients with Spinal Cord Injury

E.C. Savrunlu, S. Kabataş, E. Civelek, N. Kaplan, Osman Boyalı, M. Bozkurt, N. Küçükçakır, Erdal Karaöz

Journal of Clinical Transplantation · 2025

DOI: 10.52338/joct.2025.5082 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Transplantation, 2025. Verfasst von E.C. Savrunlu und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Savrunlu, E., Kabataş, S., Civelek, E., Kaplan, N., Boyalı, O., Bozkurt, M., Küçükçakır, N., & Karaöz, E. (2025). Efficacy and Safety of Exosomes from Whartons Jelly-Derived Mesenchymal Stem Cells in Patients with Spinal Cord Injury. Journal of Clinical Transplantation. https://doi.org/10.52338/joct.2025.5082

Vancouver

Savrunlu E, Kabataş S, Civelek E, Kaplan N, Boyalı O, Bozkurt M, et al. Efficacy and Safety of Exosomes from Whartons Jelly-Derived Mesenchymal Stem Cells in Patients with Spinal Cord Injury. Journal of Clinical Transplantation. 2025. doi:10.52338/joct.2025.5082

BibTeX
@article{Savrunlu2025,
  author = {Savrunlu, E.C. and Kabataş, S. and Civelek, E. and Kaplan, N. and Boyalı, Osman and Bozkurt, M. and Küçükçakır, N. and Karaöz, Erdal},
  title = {Efficacy and Safety of Exosomes from Whartons Jelly-Derived Mesenchymal Stem Cells in Patients with Spinal Cord Injury},
  journal = {Journal of Clinical Transplantation},
  year = {2025},
  doi = {10.52338/joct.2025.5082}
}
Kostenlos starten →